We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
-11.75%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$112B
AUM Growth
-$20.7B
(-16%)
Cap. Flow
-$1.85B
Cap. Flow
% of AUM
-1.65%
Top 10 Holdings %
Top 10 Hldgs %
32.05%
Holding
345
New
6
Increased
51
Reduced
230
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$231M |
| 2 |
Walt Disney
DIS
|
+$216M |
| 3 |
Raymond James Financial
RJF
|
+$191M |
| 4 |
Oracle
ORCL
|
+$124M |
| 5 |
Delta Air Lines
DAL
|
+$84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$447M |
| 2 |
Amazon
AMZN
|
+$368M |
| 3 |
Microsoft
MSFT
|
+$206M |
| 4 |
Bank of America
BAC
|
+$149M |
| 5 |
Eli Lilly
LLY
|
+$130M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.19% |
| 2 | Technology | 27.99% |
| 3 | Industrials | 11.8% |
| 4 | Consumer Discretionary | 9.37% |
| 5 | Financials | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Eli Lilly
LLY
$1.07T
| $9.22B | 8.24% |
28,438,488
-434,743
| -2% | -$130M |
|
|
2
Microsoft
MSFT
$2.84T
| $3.83B | 3.42% |
14,893,720
-760,773
| -5% | -$206M |
|
3
Amgen
AMGN
$203B
| $3.8B | 3.4% |
15,638,620
-87,435
| -0.6% | -$21.4M |
|
4
Biogen
BIIB
$29.9B
| $3.21B | 2.87% |
15,726,526
-108,080
| -0.7% | -$22.1M |
|
5
FedEx
FDX
$74.5B
| $3.05B | 2.72% |
13,433,592
+196,115
| +1% | +$41.9M |
|
6
AstraZeneca
AZN
$263B
| $3.03B | 2.71% |
22,906,910
-252,030
| -1% | -$33.1M |
|
7
Texas Instruments
TXN
$255B
| $2.69B | 2.41% |
17,517,767
-183,010
| -1% | -$30.8M |
|
8
Adobe
ADBE
$89.5B
| $2.37B | 2.12% |
6,471,818
-59,190
| -0.9% | -$24.1M |
|
9
Alphabet (Google) Class A
GOOGL
$3.91T
| $2.37B | 2.12% |
21,734,880
-375,300
| -2% | -$44.2M |
|
10
Tesla
TSLA
$1.24T
| $2.29B | 2.05% |
10,216,260
-128,085
| -1% | -$35M |
|
11
KLA
KLAC
$275B
| $2.29B | 2.05% |
71,813,540
-1,809,550
| -2% | -$60.8M |
|
12
Micron Technology
MU
$1.04T
| $2.23B | 2% |
40,420,216
-408,370
| -1% | -$27.7M |
|
13
Thermo Fisher Scientific
TMO
$211B
| $2.09B | 1.87% |
3,852,452
-85,055
| -2% | -$46.8M |
|
14
Sony
SONY
$123B
| $2.07B | 1.85% |
126,655,490
-2,221,550
| -2% | -$39.3M |
|
15
Alibaba
BABA
$269B
| $1.97B | 1.76% |
17,367,887
+9,340
| +0.1% | +$916K |
|
16
Wells Fargo
WFC
$261B
| $1.91B | 1.71% |
48,828,325
-504,645
| -1% | -$22.1M |
|
17
Southwest Airlines
LUV
$22.1B
| $1.91B | 1.71% |
52,919,924
-634,185
| -1% | -$27.3M |
|
|
18
Intel
INTC
$466B
| $1.82B | 1.63% |
48,598,246
+5,344,285
| +12% | +$231M |
|
19
Bristol-Myers Squibb
BMY
$127B
| $1.71B | 1.53% |
22,211,705
-158,670
| -0.7% | -$12.1M |
|
|
20
Alphabet (Google) Class C
GOOG
$3.9T
| $1.6B | 1.43% |
14,645,840
-217,600
| -1% | -$25.7M |
|
21
Novartis
NVS
$295B
| $1.49B | 1.33% |
17,604,080
-180,650
| -1% | -$15.8M |
|
22
BioMarin Pharmaceuticals
BMRN
$11.5B
| $1.47B | 1.31% |
17,678,485
-100,985
| -0.6% | -$8.04M |
|
23
Baidu
BIDU
$35.8B
| $1.42B | 1.27% |
9,557,829
+22,800
| +0.2% | +$3.01M |
|
24
Boston Scientific
BSX
$65.8B
| $1.41B | 1.26% |
37,819,609
-101,210
| -0.3% | -$4.12M |
|
25
Aecom
ACM
$9.07B
| $1.27B | 1.13% |
19,398,916
-573,720
| -3% | -$40.1M |
|
Similar funds
Primecap Management's Q2 2022 Portfolio in Review
As of Q2 2022, Primecap Management held 345 positions worth $112B, down 16% from $133B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q2 2022: portfolio turnover was 2.9%. Primecap Management opened 6 new positions and exited 4, leaving the 345-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 27% a quarter earlier, followed by Technology and Industrials.
- Primecap Management's largest Q2 2022 buy was Array Technologies: 2,382,600 shares worth $26.2M.
- Primecap Management added most to Intel in Q2 2022, an estimated $231M increase.
- Primecap Management's biggest Q2 2022 reduction was Charles Schwab, cutting an estimated $447M.
- Primecap Management fully exited Chegg in Q2 2022, selling an estimated $49.6M.
- Primecap Management's ten largest holdings make up 32% of its $112B portfolio in Q2 2022.
- Primecap Management opened 6 new positions and closed 4 in Q2 2022.
- Primecap Management's portfolio value fell 16% quarter-over-quarter to $112B.
Based on Primecap Management's 13F filing for Q2 2022, filed 11 Aug 2022.